Some Alzheimer's patients have dense amyloid plaques but mild cognitive symptoms, while others show significant cognitive decline with fewer plaques but extensive tau tangles. What does this dissociation suggest?
AAmyloid plaques directly cause cognitive decline in a dose-dependent manner, and plaque density is the best predictor of symptoms
BTau pathology correlates more closely with cognitive decline than amyloid burden, suggesting amyloid may trigger a cascade leading to tau aggregation rather than directly causing neuronal death
CPlaques are neuroprotective — dense plaques sequester toxic amyloid oligomers and reduce symptoms
DCognitive decline depends entirely on neuroinflammation, independent of both amyloid and tau
This dissociation is a well-established clinical observation that has complicated the amyloid hypothesis. Tau tangles correlate more directly with synapse loss and neuronal death than amyloid plaque burden. Current models suggest amyloid accumulation may be an early upstream trigger that eventually drives tau pathology, with tau aggregation being more proximally responsible for neurodegeneration. The most toxic amyloid forms appear to be small oligomers, not the large plaques visible on histology. This explains why some anti-amyloid therapies that successfully reduce plaques have shown limited clinical benefit.
Question 2 Multiple Choice
In a mouse model, aggregated α-synuclein injected into one brain region spreads over months to anatomically connected regions, following the pattern of neural circuits. What mechanism best explains this spread?
ANeuroinflammation spreading from activated microglia at the injection site, diffusing outward through brain tissue
BPrion-like templated misfolding — aggregated α-synuclein is released at synapses, taken up by connected neurons, and seeds the misfolding of normal endogenous α-synuclein in those cells, propagating pathology along neural circuits
CThe blood-brain barrier breaks down near aggregates, allowing α-synuclein to spread systemically through the bloodstream
DOxidative stress from aggregates causes genetic mutations in connected neurons, initiating independent aggregation events
This circuit-following spread pattern is the defining evidence for prion-like propagation in neurodegeneration. Aggregated proteins (α-synuclein, tau, TDP-43) can be released at synaptic terminals, taken up by post-synaptic neurons, and act as templates that induce the misfolding of normal protein copies in the recipient cell. The pathology follows axonal connectivity — it propagates through the brain's own wiring, which explains the predictable anatomical progression described by Braak staging in both Parkinson's and Alzheimer's diseases. This mechanism explains why neurodegeneration is relentlessly progressive.
Question 3 True / False
In neurodegenerative diseases, neuroinflammation is not merely a bystander response to dying neurons — it can actively drive disease progression by creating a positive feedback loop in which microglia and astrocytes release factors that kill additional neurons.
TTrue
FFalse
Answer: True
This is one of the most important conceptual revisions in neurodegenerative disease research. Chronically activated microglia release pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), reactive oxygen species, and other neurotoxic factors. Dying neurons release debris (protein aggregates, damage-associated molecular patterns) that further activates glia, which kill more neurons, which release more debris — a self-sustaining vicious cycle. Neuroinflammation is both consequence and cause, which is why many current therapeutic strategies target microglial activation rather than just the aggregating proteins.
Question 4 True / False
Alzheimer's disease, Parkinson's disease, and ALS are caused by accumulation of the same misfolded protein, which explains their shared pattern of progressive neurodegeneration.
TTrue
FFalse
Answer: False
Each disease involves a distinct protein: Alzheimer's features amyloid-β and tau; Parkinson's involves α-synuclein; ALS typically features TDP-43 (and sometimes SOD1 or FUS). They also affect different neuronal populations — dopaminergic neurons in the substantia nigra (Parkinson's), upper and lower motor neurons (ALS), hippocampal and cortical neurons (Alzheimer's) — and follow different anatomical progression patterns. What these diseases share are the underlying mechanisms (misfolding, aggregation, impaired clearance, neuroinflammation, prion-like spreading), not the specific proteins. Convergent mechanisms explain superficial similarity; distinct proteins and vulnerabilities explain clinical differences.
Question 5 Short Answer
What is 'prion-like spreading' in neurodegenerative disease, and why does it explain the relentlessly progressive nature of these conditions?
Think about your answer, then reveal below.
Model answer: Prion-like spreading refers to the ability of aggregated, misfolded proteins (tau, α-synuclein, TDP-43) to act as templates that induce the misfolding and aggregation of normal copies of the same protein in neighboring, anatomically connected neurons. Aggregates are released at synaptic terminals, taken up by post-synaptic cells, and seed new aggregates there. Because spread follows axonal connections, pathology propagates through the brain's own circuits in predictable anatomical patterns over years. Progression is slow because each new cell's clearance systems (proteasome, autophagy) must be overwhelmed before pathology seeds the next cell — but the spread is relentless.
The analogy to prion diseases (like CJD) is mechanistic but not identical — neurodegenerative diseases do not transmit between individuals the way classical prions do. What they share is the self-templating property of misfolded protein aggregates. This mechanism provides the most satisfying explanation for why neurodegeneration is both progressive (it spreads) and anatomically patterned (it follows circuits). Braak staging in Parkinson's disease — which describes α-synuclein pathology beginning in the olfactory bulb and gut, then ascending through the brainstem to the cortex — is direct evidence of circuit-following prion-like spread.